SARS Pneumonia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Corona Virus Infection
  • +3 more
  • High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
  • Charlottesville, Virginia
  • +1 more
2022-03-30
Mar 30, 2022
M
Recruiting
  • Covid-19
  • +3 more
  • Normal Saline
  • NDV-HXP-S vaccine
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
2022-03-13
Mar 13, 2022
U
Active, not recruiting
  • SARS-CoV 2
  • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    2022-02-01
    Feb 1, 2022
    A
    Recruiting
    • COVID-19 Pneumonia
    • +17 more
    • Not applicable (observational study)
    • Antwerpen, Belgium
    • +6 more
    2021-12-14
    Dec 14, 2021
    U
    Recruiting
    • Covid-19
    • SARS Pneumonia
    • Niclosamide Oral Tablet
    • Baghdad, Baghdada, Iraq
      Ahmed S. Abdulamir
    2021-06-19
    Jun 19, 2021
    N
    Completed
    • Covid19
    • +4 more
      • Dubai, United Arab Emirates
        NMC Specialty Hospital
      2021-05-09
      May 9, 2021
      P
      Withdrawn
      • COVID
      • +7 more
      • Ventura, California
        ProgenaBiome
      2021-04-06
      Apr 6, 2021
      P
      Withdrawn
      • COVID
      • +6 more
      • ResCure™
      • Ventura, California
        ProgenaBiome
      2021-04-06
      Apr 6, 2021
      I
      Recruiting
      • COVID-19 Disease
      • +3 more
      • COVIVAC
      • Phosphate-buffered saline
      • Hanoi, Vietnam
      • +1 more
      2021-04-01
      Apr 1, 2021
      U
      Completed
      • SARS-CoV 2
      • SARS Pneumonia
      • Therapy Intervention
      • Columbia, Missouri
        Missouri Orthopedic Institute
      2021-02-04
      Feb 4, 2021
      B
      Recruiting
      • SAR
      • SARS Pneumonia
      • Vitamin D
      • PLACEBO
      • Vitoria-Gasteiz, Alava, Spain
        Joaquín Durán Cantolla
      2020-12-22
      Dec 22, 2020
      G
      Completed
      • SARS Pneumonia
      • Convalescent Plasma of patients with COVID-19
      • placebo (hartmann plus albumine)
      • Mexico City, Mexico
      • +1 more
      2020-12-16
      Dec 16, 2020
      C
      Completed
      • Critical Illness
      • +4 more
        • Nîmes, France
          Intensive care unit CHU Nimes
        2020-12-17
        Dec 17, 2020
        C
        Recruiting
        • Dysphagia
        • +9 more
        • Fibreoptic Endoscopic Evaluation of Swallowing (FEES)
        • +3 more
        • Cambridge, United Kingdom
          Cambridge University Hospitals NHS Foundation Trust
        2020-12-10
        Dec 10, 2020
        I
        Completed
        • SARS Pneumonia
        • Respiratory mechanics measurement
        • Gas exchange measurement
        • Moscow, Russian Federation
        • +2 more
        2020-08-26
        Aug 26, 2020
        B
        Terminated
        • COVID
        • +2 more
        • São Paulo, Sao Paulo, Brazil
        • +6 more
        2020-08-22
        Aug 22, 2020
        I
        Recruiting
        • COVID-19
        • +5 more
        • Glycine
        • Mexico DF, Mexico
          Instituto Nacional de Enfermedades Respiratorias
        2020-08-20
        Aug 20, 2020
        H
        Not yet recruiting
        • COVID
        • +4 more
          • (no location specified)
          2020-07-01
          Jul 1, 2020
          T
          Completed
          • Covid-19
          • +2 more
          • Pulmonary Physiotherapy Techniques
          • Tehran, Iran, Islamic Republic of
            Imam Khomeini Hospital Complex
          2020-05-30
          May 30, 2020
          A
          Not yet recruiting
          • Covid-19
          • +2 more
          • Baricitinib Oral Tablet
          • Pisa, Italy
            Azienda Ospedaliero Universitaria Pisana
          2020-05-19
          May 19, 2020
          U
          Unknown status
          • SARS Pneumonia
          • Ancona, AN, Italy
            Università Politecnica delle Marche
          2020-04-09
          Apr 9, 2020